Ignyte Acquisition Corp. Contracts & Agreements

Side Letter Agreement re: Extension of Merger Agreement Termination Date, dated August 15, 2024, by and among the Company, Akari Therapeutics, Plc and Pegasus Merger Sub, Inc (Filed With SEC on November 14, 2024)

Form of Non-Qualified Option Grant Agreement for Non-Employee Directors (Filed With SEC on September 30, 2024)

Form of Non-Qualified Option Grant Agreement for Employees and Consultants (Filed With SEC on September 30, 2024)

Form of Separation and General Release Agreement, dated August 27, 2024, by and between Peak Bio, Inc. and Stephen LaMond (Filed With SEC on September 3, 2024)

Description of Securities (Filed With SEC on August 6, 2024)

Form of Convertible Note Agreement, dated July 12, 2024, by and between Peak Bio, Inc. and the Investors party thereto (Filed With SEC on July 17, 2024)

Form of Convertible Note Agreement, dated May 28, 2024, by and between Peak Bio, Inc. and the Investors party thereto (Filed With SEC on June 7, 2024)

Agreement and Plan of Merger, dated as of March 4,2024, by and among Akari Therapeutics, Plc, Peak Bio, Inc. and Pegasus Merger Sub, Inc (Filed With SEC on March 5, 2024)

Form of Voting and Support Agreement, dated as of March 4, 2024, by and among Akari, and certain stockholders of Peak Bio (Filed With SEC on March 5, 2024)

Form of Voting and Support Agreement, dated as of March 4, 2024, by and among Peak Bio and certain shareholders of Akari (Filed With SEC on March 5, 2024)

Form of Senior Secured Promissory Note, dated January 23, 2024, by and between Peak Bio, Inc. and the Hoyoung Huh (Filed With SEC on January 29, 2024)

Form of Security Agreement, dated January 23, 2024, by and among Peak Bio, Inc., Peak Bio Co., Ltd. Inc., Peak Bio CA, Inc. and Hoyoung Huh (Filed With SEC on January 29, 2024)

Form of Convertible Note Subscription Agreement, dated December 18, 2023, by and between Peak Bio, Inc. and the Investors party thereto (Filed With SEC on December 22, 2023)

Form of Convertible Note (Filed With SEC on December 22, 2023)

Second Amendment to Common Stock Purchase Agreement, dated as of August14, 2023, by and between Peak Bio, Inc. and White Lion Capital LLC (Filed With SEC on August 15, 2023)

Description of Securities (Filed With SEC on June 29, 2023)

Form of Convertible Note and Warrant Subscription Agreement, dated April 28, 2023, by and between Peak Bio, Inc. and the Investors party thereto (Filed With SEC on May 1, 2023)

Form of Convertible Note, dated April 28, 2023 (Filed With SEC on May 1, 2023)

Form of Warrant, dated April 28, 2023 (Filed With SEC on May 1, 2023)

Key Company Stockholder Subscription Agreement, dated April 28, 2023, by and between Peak Bio, Inc. and Hoyoung Huh (Filed With SEC on May 1, 2023)

Purchase Warrant, dated April 28, 2023, issued to Paulson Investment Company, LLC (Filed With SEC on May 1, 2023)

Second Amendment to Lock-Up Agreement, dated as of April 4, 2023 (Filed With SEC on April 21, 2023)

Key Company Stockholder Debt Conversion Agreement, dated as of April 5, 2023, by and between Peak Bio, Inc. and Hoyoung Huh (Filed With SEC on April 7, 2023)

Amendment to Common Stock Purchase Agreement, dated as of March 13, 2023, by and between Peak Bio, Inc. and White Lion Capital LLC (Filed With SEC on March 17, 2023)

Unsecured Promissory Notes, dated as of March 3, 2023, delivered by Peak Bio, Inc. to Hannol Ventures LLC (Filed With SEC on March 9, 2023)

Form of PIPE Subscription Agreement, dated as of December 30, 2022, by and between Peak Bio, Inc. and the Investor party thereto (Filed With SEC on January 4, 2023)

Form of Amendment to Lock-Up Agreement, dated as of January 4, 2023 (Filed With SEC on January 4, 2023)

Amendment to Key Company Stockholder Forward Purchase Agreement, dated as of December 29, 2022, by and between Peak Bio, Inc. and Hoyoung Huh (Filed With SEC on January 4, 2023)

Registration Rights Agreement, dated as of November 1, 2022, by and among Peak Bio, Inc., Ignyte Sponsor LLC and the Holders party thereto (Filed With SEC on November 7, 2022)

Lock-Up Agreement (Filed With SEC on November 7, 2022)

Key Company Stockholder Lock-Up Agreement (Filed With SEC on November 7, 2022)

Form of Indemnification Agreement (Filed With SEC on November 7, 2022)

Common Stock Purchase Agreement, dated as of November 3, 2022, by and between White Lion Capital, LLC and Peak Bio, Inc (Filed With SEC on November 7, 2022)

Registration Rights Agreement, dated as of November 3, 2022, by and between White Lion Capital, LLC and Peak Bio, Inc (Filed With SEC on November 7, 2022)

Form of New PIPE Subscription Agreement, dated October 31, 2022 (Filed With SEC on November 2, 2022)

Payment Agreement, dated November 1, 2022, by and between Ignyte Acquisition Corp. and Ignyte Sponsor LLC (Filed With SEC on November 2, 2022)

Payment Agreement, dated November 1, 2022, by and between Ignyte Acquisition Corp. and Ingalls & Snyder, LLC (Filed With SEC on November 2, 2022)

Form of Amended and Restated Warrant Agreement, between Ignyte Acquisition Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on November 2, 2022)

Forward Share Purchase Agreement, dated as of October 25, 2022, by and among Ignyte Acquisition Corp. and Frost Gamma Investments Trust (Filed With SEC on October 27, 2022)

Peak Bio Corporate Presentation, dated September 2022 (Filed With SEC on September 28, 2022)

Working Capital Promissory Note, dated September 20, 2022 (Filed With SEC on September 21, 2022)

Business Combination Agreement, dated as of April 28, 2022, by and among Ignyte, Korean Sub and the Target (Filed With SEC on April 29, 2022)

Form of Subscription Agreement (Filed With SEC on April 29, 2022)

Form of Key Company Stockholder Forward Purchase Agreement, dated as of April 28, 2022, by and between Ignyte and Hoyoung Huh (Filed With SEC on April 29, 2022)

Sponsor Support Agreement, dated as of April 28, 2022, by and between Ignyte and Sponsor (Filed With SEC on April 29, 2022)

Working Capital Promissory Note, dated March 21, 2022 (Filed With SEC on March 25, 2022)

Description of Securities (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and John Andrew Boockmar (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and Cheryl Cohen (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and Steven Kaplan (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and David Rosenberg (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and Richard Rosenstock (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and Ignyte Sponsor LLC (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and David J. Strupp, Jr (Filed With SEC on April 15, 2021)

Letter Agreement, dated January 27, 2021, by and among the Registrant and Charles Wilson (Filed With SEC on April 15, 2021)

Promissory Note, dated November 20, 2020, issued to David Strupp (Filed With SEC on April 15, 2021)

Promissory Note, dated November 20, 2020, issued to David Rosenberg (Filed With SEC on April 15, 2021)

Promissory Note, dated November 20, 2020, issued to Steven Kaplan (Filed With SEC on April 15, 2021)

Underwriting Agreement between Ignyte Acquisition Corp. and EarlyBirdCapital, Inc., as representative of the underwriters (Filed With SEC on February 1, 2021)

Business Combination Marketing Agreement between Ignyte Acquisition Corp. and EarlyBirdCapital, Inc (Filed With SEC on February 1, 2021)

Warrant Agreement between Ignyte Acquisition Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on February 1, 2021)

Investment Management Trust Agreement between Ignyte Acquisition Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on February 1, 2021)

Registration Rights Agreement between Ignyte Acquisition Corp. and certain security holders (Filed With SEC on February 1, 2021)

Stock Escrow Agreement between Ignyte Acquisition Corp., Ignyte Sponsor LLC, and Continental Stock Transfer & Trust Company (Filed With SEC on February 1, 2021)

Administrative Services Agreement between Ignyte Acquisition Corp. and Ignyte Sponsor LLC (Filed With SEC on February 1, 2021)

Form of Indemnification Agreement (Filed With SEC on February 1, 2021)

Form of Underwriting Agreement (Filed With SEC on January 11, 2021)

Form of Business Combination Marketing Agreement (Filed With SEC on January 11, 2021)

Specimen Unit Certificate (Filed With SEC on January 11, 2021)

Specimen Common Stock Certificate (Filed With SEC on January 11, 2021)

Specimen Warrant Certificate (Filed With SEC on January 11, 2021)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 11, 2021)

Form of Letter Agreement from each of the Registrants officers, directors and sponsor (Filed With SEC on January 11, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 11, 2021)

Promissory Note (Filed With SEC on January 11, 2021)

Form of Registration Rights Agreement (Filed With SEC on January 11, 2021)

Form of Subscription agreement for private warrants by Ignyte Sponsor LLC (Filed With SEC on January 11, 2021)

Form of Stock Escrow Agreement (Filed With SEC on January 11, 2021)

Form of Administrative Services Agreement (Filed With SEC on January 11, 2021)

Form of Indemnification Agreement (Filed With SEC on January 11, 2021)

Category

Industry

Companies

Contracts

Ignyte Acquisition Corp. Contracts & Agreements